{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:11:24Z","timestamp":1770991884705,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1124\/dmd.107.015214","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T00:53:10Z","timestamp":1181263990000},"page":"1587-1592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Pediatric Development of Glucuronidation: The Ontogeny of Hepatic UGT1A4"],"prefix":"10.1016","volume":"35","author":[{"given":"Shogo J.","family":"Miyagi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abby C.","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.107.015214_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1517\/17425255.1.3.447","article-title":"Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations","volume":"1","author":"Benedetti","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/dmd.107.015214_bib2","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0024-3205(95)02073-R","article-title":"Specificity of human UDP glucuronosyltransferases and xenobiotic glucuronidation","volume":"57","author":"Burchell","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/dmd.107.015214_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0006-2952(01)00890-5","article-title":"UDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at term","volume":"63","author":"Collier","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib4","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0026-895X(24)12047-0","article-title":"A highly sensitive fluorescent microplate method for the determination of UDP-glucuronosyl transferase activity in tissues and placental cell lines","volume":"28","author":"Collier","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib5","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/humrep\/17.10.2564","article-title":"Metabolizing enzyme localization and activities in the first trimester human placenta: the effect of maternal and gestational age, smoking and alcohol consumption","volume":"17","author":"Collier","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1124\/dmd.107.015214_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.30.2.129","article-title":"UDP glucuronosyltransferase mRNA levels in human liver disease","volume":"30","author":"Congiu","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0026-895X(25)10133-8","article-title":"The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes","volume":"34","author":"Coughtrie","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib8","series-title":"Safety of Seroxat (paroxetine) in children and adolescents under 18 years, contraindication in the treatment of depressive illness","first-page":"1","author":"Duff","year":"2003"},{"key":"10.1124\/dmd.107.015214_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/hep.20131","article-title":"Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4","volume":"39","author":"Ehmer","year":"2004","journal-title":"Hepatology"},{"key":"10.1124\/dmd.107.015214_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0090-9556(25)07570-1","article-title":"Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates","volume":"22","author":"Green","year":"1994","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0009-9236(96)90150-2","article-title":"Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans","volume":"60","author":"Hartigan-Go","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/dmd.107.015214_bib12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0090-9556(24)15358-5","article-title":"In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model","volume":"28","author":"Houston","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/bbrc.1993.1847","article-title":"cDNA cloning and expression of two new members of the human liver UDPglucuronosyltransferase 2B subfamily","volume":"194","author":"Jin","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.107.015214_bib15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1042\/bj1960257","article-title":"The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in human liver","volume":"196","author":"Kawade","year":"1981","journal-title":"Biochem J"},{"key":"10.1124\/dmd.107.015214_bib16","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1021\/bi002607y","article-title":"Isolation and characterization of the UGT2B28 cDNA encoding a novel human steroid conjugating UDP-glucuronosyltransferase","volume":"40","author":"Levesque","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.107.015214_bib17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2174\/1389200023336992","article-title":"Complexities of glucuronidation affecting in vitro in vivo extrapolation","volume":"3","author":"Lin","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.107.015214_bib18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00007691-200008000-00006","article-title":"Use of the mesoridazine\/thioridazine ratio as a marker for CYP2D6 enzyme activity","volume":"22","author":"Llerena","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1124\/dmd.107.015214_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0090-9556(25)05974-4","article-title":"Glucuronidation and deglucuronidation reactions in hepatic and extrahepatic tissues during perinatal development","volume":"5","author":"Lucier","year":"1977","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib20","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(00)02219-4","article-title":"Active monitoring of adverse drug reactions in children","volume":"355","author":"Menniti-Ippolito","year":"2000","journal-title":"Lancet"},{"key":"10.1124\/dmd.107.015214_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00181943","article-title":"A pharmacokinetic study of trifluoperazine in two ethnic populations","volume":"95","author":"Midha","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1124\/dmd.107.015214_bib22","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2125.1983.tb01515.x","article-title":"Kinetics of oral trifluoperazine disposition in man","volume":"15","author":"Midha","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib23","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/dmd.104.002576","article-title":"UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation","volume":"33","author":"Mori","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.bcp.2006.01.004","article-title":"Quaternary ammonium-linked glucuronidation of trans-4-hydroxytamoxifen, an active metabolite of tamoxifen, by human liver microsomes and UDP-glucuronosyltransferase 1A4","volume":"71","author":"Ogura","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib25","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj1840705","article-title":"Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver","volume":"184","author":"Onishi","year":"1979","journal-title":"Biochem J"},{"key":"10.1124\/dmd.107.015214_bib26","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1080\/004982599238182","article-title":"Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolites","volume":"29","author":"Pieniaszek","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.107.015214_bib27","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","article-title":"Structural and functional studies of UDP-glucuronosyl transferases","volume":"31","author":"Radominska-Pandya","year":"1999","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.107.015214_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.bpc.2003.10.022","article-title":"Redox reactions and fluorescence spectroscopic behaviour of trifluoperazine at the surface of colloidal silica","volume":"109","author":"Rele","year":"2004","journal-title":"Biophys Chem"},{"key":"10.1124\/dmd.107.015214_bib29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0021-9258(17)35280-8","article-title":"Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells","volume":"266","author":"Ritter","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.015214_bib30","doi-asserted-by":"crossref","first-page":"7900","DOI":"10.1016\/S0021-9258(19)39016-7","article-title":"Cloning and expression of human liver UDP-glucuronosyltransferase in COS-1 cells. 3,4-catechol estrogens and estriol as primary substrates","volume":"265","author":"Ritter","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.107.015214_bib31","series-title":"2000 CDC Growth Charts, United States","year":"2000"},{"key":"10.1124\/dmd.107.015214_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","article-title":"Developmental aspects of human hepatic drug glucuronidation in young children and adults","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"key":"10.1124\/dmd.107.015214_bib33","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/bcr1539","article-title":"Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants","volume":"8","author":"Sun","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1124\/dmd.107.015214_bib34","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0090-9556(24)15248-8","article-title":"A fluorescent assay amenable to measuring production of beta-D-glucuronides produced from recombinant UDP-glycosyl transferase enzymes","volume":"27","author":"Trubetskoy","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.105.007369","article-title":"Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) \u201cprobes\u201d for human UDP-glucuronosyltransferases","volume":"34","author":"Uchaipichat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/dmd.32.4.413","article-title":"Human UDP-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid","volume":"32","author":"Uchaipichat","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.107.015214_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2125.2006.02588.x","article-title":"Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation","volume":"61","author":"Uchaipichat","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib38","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/0006-2952(83)90019-9","article-title":"Binding of phenothiazine neuroleptics to plasma proteins","volume":"32","author":"Verbeeck","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/dmd.107.015214_bib39","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1093\/jn\/131.11.2967","article-title":"The reconstruction of Kleiber\u2019s law at the organ-tissue level","volume":"131","author":"Wang","year":"2001","journal-title":"J Nutr"},{"key":"10.1124\/dmd.107.015214_bib40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","article-title":"Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios","volume":"32","author":"Williams","year":"2004","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562401417X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009095562401417X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.107.015214","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:23:45Z","timestamp":1739895825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009095562401417X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S009095562401417X"],"URL":"https:\/\/doi.org\/10.1124\/dmd.107.015214","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pediatric Development of Glucuronidation: The Ontogeny of Hepatic UGT1A4","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.107.015214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}